Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutations in the
SPT5
gene of Saccharomyces cerevisiae were isolated previously as suppressors of delta insertion mutations at HIS4 and LYS2. In this study we have shown that spt5 mutations suppress the his4-912 delta and lys2-128 delta alleles by altering transcription. We cloned the
SPT5
gene and found that either an increase or a decrease in the copy number of the wild-type
SPT5
gene caused an Spt- phenotype. Construction and analysis of an spt5 null mutation demonstrated that
SPT5
is essential for growth, suggesting that
SPT5
may be required for normal transcription of a large number of genes. The
SPT5
DNA sequence was determined; it predicted a 116-kDa protein with an extremely acidic amino terminus and a novel six-amino-acid repeat at the carboxy terminus (consensus = S-T/A-W-G-G-A/Q). By indirect immunofluorescence microscopy we showed that a bifunctional
SPT5
-
beta-galactosidase
protein was located in the yeast nucleus. This molecular analysis of the
SPT5
gene revealed a number of interesting similarities to the previously characterized SPT6 gene of S. cerevisiae. These results suggest that
SPT5
and SPT6 act in a related fashion to influence essential transcriptional processes in S. cerevisiae.
...
PMID:SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. 207 20